Table 3.

Bivariate correlations for biomarkers of MS in the entire cohort and both genders adjusted for FM and Tanner stage

	SBP (mmHg)	DBP (mmHg)	hs-CRP (mg/L)	HOMA-IR (mol uU/mL)	TG: HDL-C ratio	c-peptide (pmol/L)	c-peptide: insulin ratio	HbA 1c (%)
SBP (mmHg)
Total	1.0	0.464d	0.170a	0.076	0.053	−0.002	−0.121	0.119
Male	1.0	0.444d	0.096	0.028	0.000	0.051	0.074	−0.003
Female	1.0	0.504d	0.097	−0.011	0.055	−0.133	−0.120	0.136
DBP (mmHg)
Total		1.0	0.073	0.087	0.074	0.082	−0.048	0.063
Male		1.0	0.036	−0.049	−0.016	−0.020	−0.025	−0.010
Female		1.0	0.147	0.095	0.114	0.134	−0.010	0.058
hs-CRP (mg/mL)
Total			1.0	0.433d	0.368d	0.240c	−0.425d	0.296c
Male			1.0	0.141	0.411d	0.147	0.113	0.035
Female			1.0	0.362d	0.497d	0.187	−0.309c	0.211a
HOMA-IR (mol uU/mL)
Total				1.0	0.307d	0.592d	−0.633d	0.370d
Male				1.0	0.210	0.256a	−0.228a	0.008
Female				1.0	0.261b	0.670d	−0.616d	0.357d
TG: HDL Ratio
Total					1.0	0.174a	−0.199b	0.166a
Male					1.0	0.113	0.022	0.130
Female					1.0	0.170	−0.151	0.067
c-peptide (pmol/L)
Total						1.0	0.074.	0.105
Male						1.0	0.662d	−0.153
Female						1.0	0.084	0.127
c-peptide: insulin Ratio
Total							1.0	−0.365d
Male							1.0	−0.169
Female							1.0	−0.297b
HbA 1c (%)
Total								1.0
Male								1.0
Female								1.0

^ap < 0.05, ^bp < 0.01, ^cp < 0.001, ^dp < 0.0001.